SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010891
Filing Date
2023-02-14
Accepted
2023-02-13 17:42:47
Documents
1
Group Members
VIVO CAPITAL FUND IX, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea173386-13ga2vivo_avadel.htm SC 13G/A 71999
  Complete submission text file 0001213900-23-010891.txt   73611
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 23620371
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A